Your browser doesn't support javascript.
loading
Changes in PD-1- and CTLA-4-bearing blood lymphocytes in ICU COVID-19 patients treated with Favipiravir/Kaletra or Dexamethasone/Remdesivir: a pilot study.
Mortaz, Esmaeil; Jamaati, Hamidreza; K Dezfuli, Neda; Sheikhzade, Hakime; Hashemian, Seyed MohammadReza; Roofchayee, Neda Dalil; Dastan, Frazaneh; Tabarsi, Payam; Folkerts, Gert; Garssen, Johan; Mumby, Sharon; Adcock, Ian M.
Afiliación
  • Mortaz E; Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran AND Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Jamaati H; Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran. hamidjamaati@hotmail.com.
  • K Dezfuli N; Center for Vaccine Development, University of Maryland, School of Medicine, Baltimore, MD, United States. nedadezfuli90@yahoo.com.
  • Sheikhzade H; Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran. hsheikhzade56@gmail.com.
  • Hashemian SM; Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran. smrhashemian@sbmu.ac.ir.
  • Roofchayee ND; Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran. n_dalil92@yahoo.com.
  • Dastan F; Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran AND Department of Clinical Pharmacology, Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Ira
  • Tabarsi P; Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran. payamtabarsi@yahoo.com.
  • Folkerts G; Division of Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands. G.Folkerts@uu.nl.
  • Garssen J; Division of Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands AND Department of Immunology, Danone Nutricia Research, Utrecht, The Netherlands. j.garssen@uu.nl.
  • Mumby S; National Heart and Lung Institute, Imperial College London, London, United Kingdom. s.mumby@ic.ac.uk.
  • Adcock IM; National Heart and Lung Institute, Imperial College London, London, United Kingdom. ian.adcock@imperial.ac.uk.
Iran J Allergy Asthma Immunol ; 22(1): 99-109, 2023 Feb 20.
Article en En | MEDLINE | ID: mdl-37002635
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases Asunto principal: COVID-19 Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Iran J Allergy Asthma Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Irán
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases Asunto principal: COVID-19 Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Iran J Allergy Asthma Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Irán